查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
母乳低聚醣 (HMO) 市場、份額、規模、趨勢、行業分析報告：按類型；按應用；按分銷管道；按地區；細分市場預測，2023-2032 年
市場調查報告書
商品編碼
1346940

母乳低聚醣 (HMO) 市場、份額、規模、趨勢、行業分析報告：按類型；按應用；按分銷管道；按地區；細分市場預測，2023-2032 年

Human Milk Oligosaccharides (HMO) Market Share, Size, Trends, Industry Analysis Report, By Type (2'FL, 3'FL, 3'SL, 6'SL); By Application; By Distribution Channel; By Region; Segment Forecast, 2023 - 2032
出版日期: | 出版商: Polaris Market Research | 英文 118 Pages | 商品交期: 最快1-2個工作天內

價格

根據 Polaris Market Research 的一項新研究，到 2032 年，全球母乳寡糖 (HMO) 市場規模預計將達到 17.9996 億美元。 該報告提供了對當前市場動態的詳細洞察，並對未來市場成長進行了分析。

母乳寡糖 (HMO) 是母乳中天然存在的複雜碳水化合物或糖。 HMO 是人類母乳所特有的，在其他哺乳動物（包括牛奶）的乳汁中含量並不高。

HMO 作為嬰兒的營養來源，但它們不會被嬰兒直接消化。 相反，HMO 充當益生元，餵養嬰兒腸道中的有益細菌。 您的腸道微生物組對於免疫系統發育、消化和整體健康極為重要。 HMO 選擇性地促進某些有益細菌（例如雙歧桿菌）的生長，同時抑制有害病原體的生長。

母乳寡糖 (HMO) 是母乳的重要成分，有各種濃度和成分。 HMO 的獨特性質需要特定的監管部門批准其使用。 在美國，低聚醣被批准添加到食品中，而不是被歸類為膳食補充劑，並受到公認安全 (GRAS) 法規的約束。

例如，經 GRAS 批准的 HMO 產品線是 CARE4U，由Du Pont開發，用於嬰兒配方奶粉和嬰兒食品。 此批准確保了消費安全。 此外，對 HMO 的需求不斷增長，催生了新的食品安全評估，並尋求歐盟委員會對其使用的支持。

全球對母乳寡糖 (HMO) 的採用正在增加。 根據世界經濟論壇2022年1月發表的文章，日本2020年的出生人數比前一年下降2.8%，為1899年以來的最低水準。

對 HMO 需求的增加是由於生活方式的改善以及對健康和保健的興趣增加。 HMO 用於功能性食品和飲料以及食品補充劑中，以解決疾病並緩解高風險健康狀況。 這一因素對全球 HMO 產業的成長做出了重大貢獻。 然而，與 HMO 產品相關的高成本預計將成為預測期內市場成長的主要挑戰。

COVID-19 大流行對 HMO 產業產生了重大影響。 疫情爆發之初，由於消費者恐慌性購買居家消費，對 HMO 的需求激增。 因此，被認為是增強免疫力的產品的 HMO 的銷售量增加。

母乳低聚醣 (HMO) 市場報告亮點

2022年，由於嬰兒配方奶粉設計中對HMO的需求不斷增加，嬰兒配方奶粉產業佔據了最大的市場份額。 HMO 具有益生元作用、預防感染、增強記憶、維持腸道健康和大腦發育等有益特性。 這些因素推動了嬰兒配方奶粉中 HMO 的需求。

到 2022 年，藥局或藥局細分市場在母乳低聚醣市場中佔據最高市場份額，並且預計將繼續成長。 這主要是由於在郵購零售商和超級中心的競爭日益激烈的情況下，該部門專注於客戶獲取和保留。

在亞太地區，由於人們越來越認識到母乳寡糖 (HMO) 在嬰兒營養和整體健康方面的益處，母乳低聚醣 (HMO) 市場預計將大幅成長。 隨著消費者健康意識的增強並為嬰兒尋求高品質的營養選擇，對 HMO 的需求預計將會增加。

Elicityl S.A.、Abbott Laboratories、Biosynth Carbosynth、Dextra Laboratories Ltd.、Dupont Nutrition &Biosciences、Glycosyn、BASF S.E.、Glycom A/S、Nestle Health Science、Neolacta Lifesciences Pvt.Ltd.、Royal DSM、Medolac Laboratories、遍布全球的全球母乳低聚醣產業參與者，包括Chr. Hansen Holding A/S、ZuChem、Inbiose NV、Royal FrieslandCampina N.V.

目錄

第一章簡介

第 2 章執行摘要

第三章研究方法

第四章全球母乳寡糖 (HMO) 市場洞察

  • 母乳寡糖 (HMO) - 產業快照
  • 母乳寡糖 (HMO) 市場動態
    • 推動者和機會
      • 嬰兒人口增加
      • 提高人們對母乳哺育重要性的認識
    • 抑制因素和挑戰
      • 數量有限
  • PESTEL 分析
  • 母乳寡糖 (HMO) 市場的產業趨勢
  • 價值鏈分析
  • COVID-19 感染的影響分析

第五章按類型劃分的全球母乳低聚醣 (HMO) 市場

  • 主要發現
  • 簡介
  • 2 佛羅裡達州
  • 3 佛羅裡達州
  • 3'SL
  • 6SL

第 6 章全球母乳寡糖 (HMO) 市場（依應用）

  • 主要發現
  • 簡介
  • 嬰兒配方奶粉
  • 功能性食品和飲料
  • 營養補充品

第 7 章全球母乳寡糖 (HMO) 市場（依通路）

  • 主要發現
  • 簡介
  • 大賣場與超市
  • 藥局或藥房
  • 線上銷售管道
  • 其他

第 8 章全球母乳寡糖 (HMO) 市場、地區

  • 主要發現
  • 簡介
    • 2019-2032 年母乳寡糖 (HMO) 市場評估，地區
  • 母乳寡糖 (HMO) 市場 - 北美
    • 北美：母乳寡糖 (HMO) 市場（按類型），2019-2032 年
    • 北美：母乳寡糖 (HMO) 市場（依通路），2019-2032 年
    • 北美：母乳寡糖 (HMO) 市場，按應用劃分，2019-2032 年
    • 母乳寡糖 (HMO) 市場 – 美國
    • 母乳寡糖 (HMO) 市場 - 加拿大
  • 母乳寡糖 (HMO) 市場 - 歐洲
    • 歐洲：母乳寡糖 (HMO) 市場（按類型），2019-2032 年
    • 歐洲：母乳寡糖 (HMO) 市場（依通路），2019-2032 年
    • 歐洲：母乳寡糖 (HMO) 市場，按應用劃分，2019-2032 年
    • 母乳寡糖 (HMO) 市場 - 英國
    • 母乳寡糖 (HMO) 市場 - 法國
    • 母乳寡糖 (HMO) 市場 - 德國
    • 母乳寡糖 (HMO) 市場 - 義大利
    • 母乳寡糖 (HMO) 市場 - 西班牙
    • 母乳寡糖 (HMO) 市場 - 荷蘭
    • 母乳寡糖 (HMO) 市場 - 俄羅斯
  • 母乳寡糖 (HMO) 市場 - 亞太地區
    • 亞太地區：母乳寡糖 (HMO) 市場（按類型），2019-2032 年
    • 亞太地區：母乳寡糖 (HMO) 市場（依通路），2019-2032 年
    • 亞太地區：母乳寡糖 (HMO) 市場，依應用劃分，2019-2032 年
    • 母乳寡糖 (HMO) 市場 - 中國
    • 母乳寡糖 (HMO) 市場 - 印度
    • 母乳寡糖 (HMO) 市場 - 馬來西亞
    • 母乳寡糖 (HMO) 市場 - 日本
    • 母乳寡糖 (HMO) 市場 - 印尼
    • 母乳寡糖 (HMO) 市場 - 韓國
  • 母乳寡糖 (HMO) 市場 - 中東和非洲
    • 中東和非洲：母乳寡糖 (HMO) 市場（按類型），2019-2032 年
    • 中東和非洲：母乳低聚醣 (HMO) 市場（按分銷管道），2019-2032 年
    • 中東和非洲：母乳寡糖 (HMO) 市場，按應用劃分，2019-2032 年
    • 母乳寡糖 (HMO) 市場 - 沙烏地阿拉伯
    • 母乳寡糖 (HMO) 市場 - 阿拉伯聯合大公國
    • 母乳寡糖 (HMO) 市場 - 以色列
    • 母乳寡糖 (HMO) 市場 - 南非
  • 母乳寡糖 (HMO) 市場 - 拉丁美洲
    • 拉丁美洲：母乳寡糖 (HMO) 市場（按類型），2019-2032 年
    • 拉丁美洲：母乳寡糖 (HMO) 市場，依通路劃分，2019-2032 年
    • 拉丁美洲：母乳寡糖 (HMO) 市場，按應用劃分，2019-2032 年
    • 母乳寡糖 (HMO) 市場 - 墨西哥
    • 母乳寡糖 (HMO) 市場 - 巴西
    • 母乳寡糖 (HMO) 市場 - 阿根廷

第九章競爭態勢

  • 擴張與收購分析
    • 放大
    • 收購
  • 夥伴關係/協作/協議/揭露

第十章公司簡介

  • Abbott Laboratories
  • BASF S.E
  • Biosynth Carbosynth
  • Chr. Hansen Holding A/S
  • Dextra Laboratories Ltd
  • Dupont Nutrition & Biosciences
  • Elicityl S.A.
  • Glycom A/S
  • Glycosyn
  • Inbiose NV
  • Medolac Laboratories
  • Neolacta Lifesciences Pvt. Ltd
  • Nestle Health Science
  • Royal DSM
  • Royal FrieslandCampina N.V
  • ZuChem
Product Code: PM2516

The global human milk oligosaccharides (HMO) market size is expected to reach USD 1,799.96 million by 2032, according to a new study by Polaris Market Research. The report "Human Milk Oligosaccharides (HMO) Market Share, Size, Trends, Industry Analysis Report, By Type (2'FL, 3'FL, 3'SL, 6'SL); By Application; By Distribution Channel; By Region; Segment Forecast, 2023 - 2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.

Human Milk Oligosaccharides (HMOs) are complex carbohydrates or sugars naturally found in human breast milk. HMOs are unique to human milk and are not present in significant amounts in other mammalian milk, including cow's milk.

HMOs serve as a source of infant nutrition, although the baby does not directly digest them. Instead, they act as prebiotics, which means they serve as food for beneficial bacteria in the infant's gut. The gut microbiota is crucial in immune system development, digestion, and overall health. HMOs selectively promote the growth of specific beneficial bacteria, such as Bifidobacteria, while inhibiting the growth of harmful pathogens.

Human Milk Oligosaccharides (HMOs) are essential constituents of human breast milk and are available in various concentrations and compositions. The unique nature of HMOs requires specific regulatory approvals for their use. In the United States, oligosaccharides are authorized to be incorporated into food products rather than categorized as dietary supplements and are subject to the Generally Recognized as Safe (GRAS) regulations.

For instance, the GRAS-approved HMO product line is CARE4U, developed by DuPont, which is utilized in infant formula and toddler foods. This approval ensures its safety for consumption. Furthermore, the growing demand for HMOs has led to a novel food safety assessment to seek support from the European Commission for their usage.

The global adoption of Human Milk Oligosaccharides (HMOs) has increased. According to a World Economic Forum article published in January 2022, the number of births in Japan decreased by 2.8% in 2020 compared to the previous year, reaching its lowest point since 1899.

The increasing demand for HMOs can be attributed to lifestyle improvements and a growing focus on health and wellness. HMOs are utilized in functional food and beverage products and food supplements to address disorders and mitigate high-risk health conditions. This factor has significantly contributed to the growth of the global HMO industry. However, the high costs associated with HMO products are expected to pose a major challenge to market growth during the forecast period.

The COVID-19 pandemic has had a significant impact on the HMO industry. During the initial phase of the pandemic, there was a surge in demand for HMOs as consumers engaged in panic buying for at-home consumption. It resulted in increased sales of HMOs, considered immune-boosting products.

Human Milk Oligosaccharides (HMO) Market Report Highlights

In 2022, the infant formula segment accounted for the largest market share due to the increasing demand for HMOs in infant formula design. HMOs offer beneficial properties like prebiotic effects, infection prevention, memory enhancement, gut health maintenance, and brain development. These factors drive the demand for HMOs in infant formulas.

In 2022, the drug store or pharmacy segment held the highest market share in the Human Milk Oligosaccharides market and is projected to continue growing. It is primarily due to the segment's focus on attracting and retaining customers amidst rising competition from mail-order retailers and supercenters.

The Asia Pacific region expected to witness significant growth in the Human Milk Oligosaccharides (HMO) market due to growing awareness of the benefits of HMOs in infant nutrition and overall health in the region. As consumers become more health-conscious and seek high-quality nutrition options for their infants, the demand for HMOs is expected to rise.

The global Human Milk Oligosaccharides industry players with a global presence including Elicityl S.A., Abbott Laboratories, Biosynth Carbosynth, Dextra Laboratories Ltd., Dupont Nutrition & Biosciences, Glycosyn, BASF S.E., Glycom A/S, Nestle Health Science, Neolacta Lifesciences Pvt. Ltd, Royal DSM, Medolac Laboratories, Chr. Hansen Holding A/S, ZuChem, Inbiose NV, and Royal FrieslandCampina N.V.

Polaris Market Research has segmented the human milk oligosaccharides (HMO) market report based on type, application, distribution channel, and region:

Human Milk Oligosaccharides (HMO), Type Outlook (Revenue - USD Million, 2019 - 2032)

  • 2'FL
  • 3'FL
  • 3'SL
  • 6'SL

Human Milk Oligosaccharides (HMO), Application Outlook (Revenue - USD Million, 2019 - 2032)

  • Infant Formula
  • Functional Food & Beverage
  • Food Supplements

Human Milk Oligosaccharides (HMO), Distribution Channel Outlook (Revenue - USD Million, 2019 - 2032)

  • Hypermarkets & Supermarkets
  • Drug Store or Pharmacy
  • Online Sales Channel
  • Others

Fogless Mirror, Regional Outlook (Revenue - USD Million, 2019 - 2032)

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Russia
    • Netherlands
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
    • Indonesia
    • Malaysia
  • Latin America
    • Argentina
    • Brazil
    • Mexico
  • Middle East & Africa
    • UAE
    • Saudi Arabia
    • Israel
    • South Africa

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Human Milk Oligosaccharides (HMO) Market Insights

  • 4.1. Human Milk Oligosaccharides (HMO) - Industry Snapshot
  • 4.2. Human Milk Oligosaccharides (HMO) Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Increase in the infant population
      • 4.2.1.2. Growing awareness of the importance of breastfeeding
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. Limited availability
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTEL Analysis
  • 4.5. Human Milk Oligosaccharides (HMO) Market Industry Trends
  • 4.6. Value Chain Analysis
  • 4.7. COVID-19 Impact Analysis

5. Global Human Milk Oligosaccharides (HMO) Market, by Type

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Human Milk Oligosaccharides (HMO) Market, by Type, 2019 - 2032 (USD Million)
  • 5.3. 2'FL
    • 5.3.1. Global Human Milk Oligosaccharides (HMO) Market, by 2'FL, by Region, 2019 - 2032 (USD Million)
  • 5.4. 3'FL
    • 5.4.1. Global Human Milk Oligosaccharides (HMO) Market, by 3'FL, by Region, 2019 - 2032 (USD Million)
  • 5.5. 3'SL
    • 5.5.1. Global Human Milk Oligosaccharides (HMO) Market, by 3'SL, by Region, 2019 - 2032 (USD Million)
  • 5.6. 6'SL
    • 5.6.1. Global Human Milk Oligosaccharides (HMO) Market, by 6'SL, by Region, 2019 - 2032 (USD Million)

6. Global Human Milk Oligosaccharides (HMO) Market, by Application

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Human Milk Oligosaccharides (HMO) Market, by Application, 2019 - 2032 (USD Million)
  • 6.3. Infant Formula
    • 6.3.1. Global Human Milk Oligosaccharides (HMO) Market, by Infant Formula, by Region, 2019 - 2032 (USD Million)
  • 6.4. Functional Food & Beverage
    • 6.4.1. Global Human Milk Oligosaccharides (HMO) Market, by Functional Food & Beverage, by Region, 2019 - 2032 (USD Million)
  • 6.5. Food Supplements
    • 6.5.1. Global Human Milk Oligosaccharides (HMO) Market, by Food Supplements, by Region, 2019 - 2032 (USD Million)

7. Global Human Milk Oligosaccharides (HMO) Market, by Distribution channel

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global Human Milk Oligosaccharides (HMO) Market, by Distribution channel, 2019 - 2032 (USD Million)
  • 7.3. Hypermarkets & Supermarkets
    • 7.3.1. Global Human Milk Oligosaccharides (HMO) Market, by Hypermarkets & Supermarkets, by Region, 2019 - 2032 (USD Million)
  • 7.4. Drug Store or Pharmacy
    • 7.4.1. Global Human Milk Oligosaccharides (HMO) Market, by Drug Store or Pharmacy, by Region, 2019 - 2032 (USD Million)
  • 7.5. Online Sales Channel
    • 7.5.1. Global Human Milk Oligosaccharides (HMO) Market, by Online Sales Channel, by Region, 2019 - 2032 (USD Million)
  • 7.6. Others
    • 7.6.1. Global Human Milk Oligosaccharides (HMO) Market, by Others, by Region, 2019 - 2032 (USD Million)

8. Global Human Milk Oligosaccharides (HMO) Market, by Geography

  • 8.1. Key findings
  • 8.2. Introduction
    • 8.2.1. Human Milk Oligosaccharides (HMO) Market Assessment, By Geography, 2019 - 2032 (USD Million)
  • 8.3. Human Milk Oligosaccharides (HMO) Market - North America
    • 8.3.1. North America: Human Milk Oligosaccharides (HMO) Market, by Type, 2019 - 2032 (USD Million)
    • 8.3.2. North America: Human Milk Oligosaccharides (HMO) Market, by Distribution channel, 2019 - 2032 (USD Million)
    • 8.3.3. North America: Human Milk Oligosaccharides (HMO) Market, by Application, 2019 - 2032 (USD Million)
    • 8.3.4. Human Milk Oligosaccharides (HMO) Market - U.S.
      • 8.3.4.1. U.S.: Human Milk Oligosaccharides (HMO) Market, by Type, 2019 - 2032 (USD Million)
      • 8.3.4.2. U.S.: Human Milk Oligosaccharides (HMO) Market, by Distribution channel, 2019 - 2032 (USD Million)
      • 8.3.4.3. U.S.: Human Milk Oligosaccharides (HMO) Market, by Application, 2019 - 2032 (USD Million)
    • 8.3.5. Human Milk Oligosaccharides (HMO) Market - Canada
      • 8.3.5.1. Canada: Human Milk Oligosaccharides (HMO) Market, by Type, 2019 - 2032 (USD Million)
      • 8.3.5.2. Canada.: Human Milk Oligosaccharides (HMO) Market, by Distribution channel, 2019 - 2032 (USD Million)
      • 8.3.5.3. Canada: Human Milk Oligosaccharides (HMO) Market, by Application, 2019 - 2032 (USD Million)
  • 8.4. Human Milk Oligosaccharides (HMO) Market - Europe
    • 8.4.1. Europe: Human Milk Oligosaccharides (HMO) Market, by Type, 2019 - 2032 (USD Million)
    • 8.4.2. Europe.: Human Milk Oligosaccharides (HMO) Market, by Distribution channel, 2019 - 2032 (USD Million)
    • 8.4.3. Europe: Human Milk Oligosaccharides (HMO) Market, by Application, 2019 - 2032 (USD Million)
    • 8.4.4. Human Milk Oligosaccharides (HMO) Market - UK
      • 8.4.4.1. UK: Human Milk Oligosaccharides (HMO) Market, by Type, 2019 - 2032 (USD Million)
      • 8.4.4.2. UK.: Human Milk Oligosaccharides (HMO) Market, by Distribution channel, 2019 - 2032 (USD Million)
      • 8.4.4.3. UK: Human Milk Oligosaccharides (HMO) Market, by Application, 2019 - 2032 (USD Million)
    • 8.4.5. Human Milk Oligosaccharides (HMO) Market - France
      • 8.4.5.1. France: Human Milk Oligosaccharides (HMO) Market, by Type, 2019 - 2032 (USD Million)
      • 8.4.5.2. France.: Human Milk Oligosaccharides (HMO) Market, by Distribution channel, 2019 - 2032 (USD Million)
      • 8.4.5.3. France: Human Milk Oligosaccharides (HMO) Market, by Application, 2019 - 2032 (USD Million)
    • 8.4.6. Human Milk Oligosaccharides (HMO) Market - Germany
      • 8.4.6.1. Germany: Human Milk Oligosaccharides (HMO) Market, by Type, 2019 - 2032 (USD Million)
      • 8.4.6.2. Germany.: Human Milk Oligosaccharides (HMO) Market, by Distribution channel, 2019 - 2032 (USD Million)
      • 8.4.6.3. Germany: Human Milk Oligosaccharides (HMO) Market, by Application, 2019 - 2032 (USD Million)
    • 8.4.7. Human Milk Oligosaccharides (HMO) Market - Italy
      • 8.4.7.1. Italy: Human Milk Oligosaccharides (HMO) Market, by Type, 2019 - 2032 (USD Million)
      • 8.4.7.2. Italy.: Human Milk Oligosaccharides (HMO) Market, by Distribution channel, 2019 - 2032 (USD Million)
      • 8.4.7.3. Italy: Human Milk Oligosaccharides (HMO) Market, by Application, 2019 - 2032 (USD Million)
    • 8.4.8. Human Milk Oligosaccharides (HMO) Market - Spain
      • 8.4.8.1. Spain: Human Milk Oligosaccharides (HMO) Market, by Type, 2019 - 2032 (USD Million)
      • 8.4.8.2. Spain.: Human Milk Oligosaccharides (HMO) Market, by Distribution channel, 2019 - 2032 (USD Million)
      • 8.4.8.3. Spain: Human Milk Oligosaccharides (HMO) Market, by Application, 2019 - 2032 (USD Million)
    • 8.4.9. Human Milk Oligosaccharides (HMO) Market - Netherlands
      • 8.4.9.1. Netherlands: Human Milk Oligosaccharides (HMO) Market, by Type, 2019 - 2032 (USD Million)
      • 8.4.9.2. Netherlands.: Human Milk Oligosaccharides (HMO) Market, by Distribution channel, 2019 - 2032 (USD Million)
      • 8.4.9.3. Netherlands: Human Milk Oligosaccharides (HMO) Market, by Application, 2019 - 2032 (USD Million)
    • 8.4.10. Human Milk Oligosaccharides (HMO) Market - Russia
      • 8.4.10.1. Russia: Human Milk Oligosaccharides (HMO) Market, by Type, 2019 - 2032 (USD Million)
      • 8.4.10.2. Russia.: Human Milk Oligosaccharides (HMO) Market, by Distribution channel, 2019 - 2032 (USD Million)
      • 8.4.10.3. Russia: Human Milk Oligosaccharides (HMO) Market, by Application, 2019 - 2032 (USD Million)
  • 8.5. Human Milk Oligosaccharides (HMO) Market - Asia Pacific
    • 8.5.1. Asia Pacific: Human Milk Oligosaccharides (HMO) Market, by Type, 2019 - 2032 (USD Million)
    • 8.5.2. Asia Pacific.: Human Milk Oligosaccharides (HMO) Market, by Distribution channel, 2019 - 2032 (USD Million)
    • 8.5.3. Asia Pacific: Human Milk Oligosaccharides (HMO) Market, by Application, 2019 - 2032 (USD Million)
    • 8.5.4. Human Milk Oligosaccharides (HMO) Market - China
      • 8.5.4.1. China: Human Milk Oligosaccharides (HMO) Market, by Type, 2019 - 2032 (USD Million)
      • 8.5.4.2. China.: Human Milk Oligosaccharides (HMO) Market, by Distribution channel, 2019 - 2032 (USD Million)
      • 8.5.4.3. China: Human Milk Oligosaccharides (HMO) Market, by Application, 2019 - 2032 (USD Million)
    • 8.5.5. Human Milk Oligosaccharides (HMO) Market - India
      • 8.5.5.1. India: Human Milk Oligosaccharides (HMO) Market, by Type, 2019 - 2032 (USD Million)
      • 8.5.5.2. India.: Human Milk Oligosaccharides (HMO) Market, by Distribution channel, 2019 - 2032 (USD Million)
      • 8.5.5.3. India: Human Milk Oligosaccharides (HMO) Market, by Application, 2019 - 2032 (USD Million)
    • 8.5.6. Human Milk Oligosaccharides (HMO) Market - Malaysia
      • 8.5.6.1. Malaysia: Human Milk Oligosaccharides (HMO) Market, by Type, 2019 - 2032 (USD Million)
      • 8.5.6.2. Malaysia.: Human Milk Oligosaccharides (HMO) Market, by Distribution channel, 2019 - 2032 (USD Million)
      • 8.5.6.3. Malaysia: Human Milk Oligosaccharides (HMO) Market, by Application, 2019 - 2032 (USD Million)
    • 8.5.7. Human Milk Oligosaccharides (HMO) Market - Japan
      • 8.5.7.1. Japan: Human Milk Oligosaccharides (HMO) Market, by Type, 2019 - 2032 (USD Million)
      • 8.5.7.2. Japan.: Human Milk Oligosaccharides (HMO) Market, by Distribution channel, 2019 - 2032 (USD Million)
      • 8.5.7.3. Japan: Human Milk Oligosaccharides (HMO) Market, by Application, 2019 - 2032 (USD Million)
    • 8.5.8. Human Milk Oligosaccharides (HMO) Market - Indonesia
      • 8.5.8.1. Indonesia: Human Milk Oligosaccharides (HMO) Market, by Type, 2019 - 2032 (USD Million)
      • 8.5.8.2. Indonesia.: Human Milk Oligosaccharides (HMO) Market, by Distribution channel, 2019 - 2032 (USD Million)
      • 8.5.8.3. Indonesia: Human Milk Oligosaccharides (HMO) Market, by Application, 2019 - 2032 (USD Million)
    • 8.5.9. Human Milk Oligosaccharides (HMO) Market - South Korea
      • 8.5.9.1. South Korea: Human Milk Oligosaccharides (HMO) Market, by Type, 2019 - 2032 (USD Million)
      • 8.5.9.2. South Korea.: Human Milk Oligosaccharides (HMO) Market, by Distribution channel, 2019 - 2032 (USD Million)
      • 8.5.9.3. South Korea: Human Milk Oligosaccharides (HMO) Market, by Application, 2019 - 2032 (USD Million)
  • 8.6. Human Milk Oligosaccharides (HMO) Market - Middle East & Africa
    • 8.6.1. Middle East & Africa: Human Milk Oligosaccharides (HMO) Market, by Type, 2019 - 2032 (USD Million)
    • 8.6.2. Middle East & Africa.: Human Milk Oligosaccharides (HMO) Market, by Distribution channel, 2019 - 2032 (USD Million)
    • 8.6.3. Middle East & Africa: Human Milk Oligosaccharides (HMO) Market, by Application, 2019 - 2032 (USD Million)
    • 8.6.4. Human Milk Oligosaccharides (HMO) Market - Saudi Arabia
      • 8.6.4.1. Saudi Arabia: Human Milk Oligosaccharides (HMO) Market, by Type, 2019 - 2032 (USD Million)
      • 8.6.4.2. Saudi Arabia.: Human Milk Oligosaccharides (HMO) Market, by Distribution channel, 2019 - 2032 (USD Million)
      • 8.6.4.3. Saudi Arabia: Human Milk Oligosaccharides (HMO) Market, by Application, 2019 - 2032 (USD Million)
    • 8.6.5. Human Milk Oligosaccharides (HMO) Market - UAE
      • 8.6.5.1. UAE: Human Milk Oligosaccharides (HMO) Market, by Type, 2019 - 2032 (USD Million)
      • 8.6.5.2. UAE.: Human Milk Oligosaccharides (HMO) Market, by Distribution channel, 2019 - 2032 (USD Million)
      • 8.6.5.3. UAE: Human Milk Oligosaccharides (HMO) Market, by Application, 2019 - 2032 (USD Million)
    • 8.6.6. Human Milk Oligosaccharides (HMO) Market - Israel
      • 8.6.6.1. Israel: Human Milk Oligosaccharides (HMO) Market, by Type, 2019 - 2032 (USD Million)
      • 8.6.6.2. Israel.: Human Milk Oligosaccharides (HMO) Market, by Distribution channel, 2019 - 2032 (USD Million)
      • 8.6.6.3. Israel: Human Milk Oligosaccharides (HMO) Market, by Application, 2019 - 2032 (USD Million)
    • 8.6.7. Human Milk Oligosaccharides (HMO) Market - South Africa
      • 8.6.7.1. South Africa: Human Milk Oligosaccharides (HMO) Market, by Type, 2019 - 2032 (USD Million)
      • 8.6.7.2. South Africa.: Human Milk Oligosaccharides (HMO) Market, by Distribution channel, 2019 - 2032 (USD Million)
      • 8.6.7.3. South Africa: Human Milk Oligosaccharides (HMO) Market, by Application, 2019 - 2032 (USD Million)
  • 8.7. Human Milk Oligosaccharides (HMO) Market - Latin America
    • 8.7.1. Latin America: Human Milk Oligosaccharides (HMO) Market, by Type, 2019 - 2032 (USD Million)
    • 8.7.2. Latin America.: Human Milk Oligosaccharides (HMO) Market, by Distribution channel, 2019 - 2032 (USD Million)
    • 8.7.3. Latin America: Human Milk Oligosaccharides (HMO) Market, by Application, 2019 - 2032 (USD Million)
    • 8.7.4. Human Milk Oligosaccharides (HMO) Market - Mexico
      • 8.7.4.1. Mexico: Human Milk Oligosaccharides (HMO) Market, by Type, 2019 - 2032 (USD Million)
      • 8.7.4.2. Mexico.: Human Milk Oligosaccharides (HMO) Market, by Distribution channel, 2019 - 2032 (USD Million)
      • 8.7.4.3. Mexico: Human Milk Oligosaccharides (HMO) Market, by Application, 2019 - 2032 (USD Million)
    • 8.7.5. Human Milk Oligosaccharides (HMO) Market - Brazil
      • 8.7.5.1. Brazil: Human Milk Oligosaccharides (HMO) Market, by Type, 2019 - 2032 (USD Million)
      • 8.7.5.2. Brazil.: Human Milk Oligosaccharides (HMO) Market, by Distribution channel, 2019 - 2032 (USD Million)
      • 8.7.5.3. Brazil: Human Milk Oligosaccharides (HMO) Market, by Application, 2019 - 2032 (USD Million)
    • 8.7.6. Human Milk Oligosaccharides (HMO) Market - Argentina
      • 8.7.6.1. Argentina: Human Milk Oligosaccharides (HMO) Market, by Type, 2019 - 2032 (USD Million)
      • 8.7.6.2. Argentina.: Human Milk Oligosaccharides (HMO) Market, by Distribution channel, 2019 - 2032 (USD Million)
      • 8.7.6.3. Argentina: Human Milk Oligosaccharides (HMO) Market, by Application, 2019 - 2032 (USD Million)

9. Competitive Landscape

  • 9.1. Expansion and Acquisition Analysis
    • 9.1.1. Expansion
    • 9.1.2. Acquisitions
  • 9.2. Partnerships/Collaborations/Agreements/Exhibitions

10. Company Profiles

  • 10.1. Abbott Laboratories
    • 10.1.1. Company Overview
    • 10.1.2. Financial Performance
    • 10.1.3. Product Benchmarking
    • 10.1.4. Recent Development
  • 10.2. BASF S.E
    • 10.2.1. Company Overview
    • 10.2.2. Financial Performance
    • 10.2.3. Product Benchmarking
    • 10.2.4. Recent Development
  • 10.3. Biosynth Carbosynth
    • 10.3.1. Company Overview
    • 10.3.2. Financial Performance
    • 10.3.3. Product Benchmarking
    • 10.3.4. Recent Development
  • 10.4. Chr. Hansen Holding A/S
    • 10.4.1. Company Overview
    • 10.4.2. Financial Performance
    • 10.4.3. Product Benchmarking
    • 10.4.4. Recent Development
  • 10.5. Dextra Laboratories Ltd
    • 10.5.1. Company Overview
    • 10.5.2. Financial Performance
    • 10.5.3. Product Benchmarking
    • 10.5.4. Recent Development
  • 10.6. Dupont Nutrition & Biosciences
    • 10.6.1. Company Overview
    • 10.6.2. Financial Performance
    • 10.6.3. Product Benchmarking
    • 10.6.4. Recent Development
  • 10.7. Elicityl S.A.
    • 10.7.1. Company Overview
    • 10.7.2. Financial Performance
    • 10.7.3. Product Benchmarking
    • 10.7.4. Recent Development
  • 10.8. Glycom A/S
    • 10.8.1. Company Overview
    • 10.8.2. Financial Performance
    • 10.8.3. Product Benchmarking
    • 10.8.4. Recent Development
  • 10.9. Glycosyn
    • 10.9.1. Company Overview
    • 10.9.2. Financial Performance
    • 10.9.3. Product Benchmarking
    • 10.9.4. Recent Development
  • 10.10. Inbiose NV
    • 10.10.1. Company Overview
    • 10.10.2. Financial Performance
    • 10.10.3. Product Benchmarking
    • 10.10.4. Recent Development
  • 10.11. Medolac Laboratories
    • 10.11.1. Company Overview
    • 10.11.2. Financial Performance
    • 10.11.3. Product Benchmarking
    • 10.11.4. Recent Development
  • 10.12. Neolacta Lifesciences Pvt. Ltd
    • 10.12.1. Company Overview
    • 10.12.2. Financial Performance
    • 10.12.3. Product Benchmarking
    • 10.12.4. Recent Development
  • 10.13. Nestle Health Science
    • 10.13.1. Company Overview
    • 10.13.2. Financial Performance
    • 10.13.3. Product Benchmarking
    • 10.13.4. Recent Development
  • 10.14. Royal DSM
    • 10.14.1. Company Overview
    • 10.14.2. Financial Performance
    • 10.14.3. Product Benchmarking
    • 10.14.4. Recent Development
  • 10.15. Royal FrieslandCampina N.V
    • 10.15.1. Company Overview
    • 10.15.2. Financial Performance
    • 10.15.3. Product Benchmarking
    • 10.15.4. Recent Development
  • 10.16. ZuChem
    • 10.16.1. Company Overview
    • 10.16.2. Financial Performance
    • 10.16.3. Product Benchmarking
    • 10.16.4. Recent Development

List of Tables

  • Table 1 Global Human Milk Oligosaccharides (HMO) Market, by Type, 2019 - 2032 (USD Million)
  • Table 2 Global Human Milk Oligosaccharides (HMO) Market, by Application, 2019 - 2032 (USD Million)
  • Table 3 Global Human Milk Oligosaccharides (HMO) Market, by Distribution channel, 2019 - 2032 (USD Million)
  • Table 4 Human Milk Oligosaccharides (HMO) Market Assessment, By Geography, 2019 - 2032 (USD Million)
  • Table 5 North America: Human Milk Oligosaccharides (HMO) Market, by Type, 2019 - 2032 (USD Million)
  • Table 6 North America: Human Milk Oligosaccharides (HMO) Market, by Application, 2019 - 2032 (USD Million)
  • Table 7 North America: Human Milk Oligosaccharides (HMO) Market, by Distribution channel, 2019 - 2032 (USD Million)
  • Table 8 U.S.: Human Milk Oligosaccharides (HMO) Market, by Type, 2019 - 2032 (USD Million)
  • Table 9 U.S.: Human Milk Oligosaccharides (HMO) Market, by Application, 2019 - 2032 (USD Million)
  • Table 10 U.S.: Human Milk Oligosaccharides (HMO) Market, by Distribution channel, 2019 - 2032 (USD Million)
  • Table 11 Canada: Human Milk Oligosaccharides (HMO) Market, by Type, 2019 - 2032 (USD Million)
  • Table 12 Canada: Human Milk Oligosaccharides (HMO) Market, by Application, 2019 - 2032 (USD Million)
  • Table 13 Canada: Human Milk Oligosaccharides (HMO) Market, by Distribution channel, 2019 - 2032 (USD Million)
  • Table 14 Europe: Human Milk Oligosaccharides (HMO) Market, by Type, 2019 - 2032 (USD Million)
  • Table 15 Europe: Human Milk Oligosaccharides (HMO) Market, by Application, 2019 - 2032 (USD Million)
  • Table 16 Europe: Human Milk Oligosaccharides (HMO) Market, by Distribution channel, 2019 - 2032 (USD Million)
  • Table 17 UK: Human Milk Oligosaccharides (HMO) Market, by Type, 2019 - 2032 (USD Million)
  • Table 18 UK: Human Milk Oligosaccharides (HMO) Market, by Application, 2019 - 2032 (USD Million)
  • Table 19 UK: Human Milk Oligosaccharides (HMO) Market, by Distribution channel, 2019 - 2032 (USD Million)
  • Table 20 France: Human Milk Oligosaccharides (HMO) Market, by Type, 2019 - 2032 (USD Million)
  • Table 21 France: Human Milk Oligosaccharides (HMO) Market, by Application, 2019 - 2032 (USD Million)
  • Table 22 France: Human Milk Oligosaccharides (HMO) Market, by Distribution channel, 2019 - 2032 (USD Million)
  • Table 23 Germany: Human Milk Oligosaccharides (HMO) Market, by Type, 2019 - 2032 (USD Million)
  • Table 24 Germany: Human Milk Oligosaccharides (HMO) Market, by Application, 2019 - 2032 (USD Million)
  • Table 25 Germany: Human Milk Oligosaccharides (HMO) Market, by Distribution channel, 2019 - 2032 (USD Million)
  • Table 26 Italy: Human Milk Oligosaccharides (HMO) Market, by Type, 2019 - 2032 (USD Million)
  • Table 27 Italy: Human Milk Oligosaccharides (HMO) Market, by Application, 2019 - 2032 (USD Million)
  • Table 28 Italy: Human Milk Oligosaccharides (HMO) Market, by Distribution channel, 2019 - 2032 (USD Million)
  • Table 29 Spain: Human Milk Oligosaccharides (HMO) Market, by Type, 2019 - 2032 (USD Million)
  • Table 30 Spain: Human Milk Oligosaccharides (HMO) Market, by Application, 2019 - 2032 (USD Million)
  • Table 31 Spain: Human Milk Oligosaccharides (HMO) Market, by Distribution channel, 2019 - 2032 (USD Million)
  • Table 32 Netherlands: Human Milk Oligosaccharides (HMO) Market, by Type, 2019 - 2032 (USD Million)
  • Table 33 Netherlands: Human Milk Oligosaccharides (HMO) Market, by Application, 2019 - 2032 (USD Million)
  • Table 34 Netherlands: Human Milk Oligosaccharides (HMO) Market, by Distribution channel, 2019 - 2032 (USD Million)
  • Table 35 Russia: Human Milk Oligosaccharides (HMO) Market, by Type, 2019 - 2032 (USD Million)
  • Table 36 Russia: Human Milk Oligosaccharides (HMO) Market, by Application, 2019 - 2032 (USD Million)
  • Table 37 Russia: Human Milk Oligosaccharides (HMO) Market, by Distribution channel, 2019 - 2032 (USD Million)
  • Table 38 Asia Pacific: Human Milk Oligosaccharides (HMO) Market, by Type, 2019 - 2032 (USD Million)
  • Table 39 Asia Pacific: Human Milk Oligosaccharides (HMO) Market, by Application, 2019 - 2032 (USD Million)
  • Table 40 Asia Pacific: Human Milk Oligosaccharides (HMO) Market, by Distribution channel, 2019 - 2032 (USD Million)
  • Table 41 China: Human Milk Oligosaccharides (HMO) Market, by Type, 2019 - 2032 (USD Million)
  • Table 42 China: Human Milk Oligosaccharides (HMO) Market, by Application, 2019 - 2032 (USD Million)
  • Table 43 China: Human Milk Oligosaccharides (HMO) Market, by Distribution channel, 2019 - 2032 (USD Million)
  • Table 44 India: Human Milk Oligosaccharides (HMO) Market, by Type, 2019 - 2032 (USD Million)
  • Table 45 India: Human Milk Oligosaccharides (HMO) Market, by Application, 2019 - 2032 (USD Million)
  • Table 46 India: Human Milk Oligosaccharides (HMO) Market, by Distribution channel, 2019 - 2032 (USD Million)
  • Table 47 Malaysia: Human Milk Oligosaccharides (HMO) Market, by Type, 2019 - 2032 (USD Million)
  • Table 48 Malaysia: Human Milk Oligosaccharides (HMO) Market, by Application, 2019 - 2032 (USD Million)
  • Table 49 Malaysia: Human Milk Oligosaccharides (HMO) Market, by Distribution channel, 2019 - 2032 (USD Million)
  • Table 50 Japan: Human Milk Oligosaccharides (HMO) Market, by Type, 2019 - 2032 (USD Million)
  • Table 51 Japan: Human Milk Oligosaccharides (HMO) Market, by Application, 2019 - 2032 (USD Million)
  • Table 52 Japan: Human Milk Oligosaccharides (HMO) Market, by Distribution channel, 2019 - 2032 (USD Million)
  • Table 53 Indonesia: Human Milk Oligosaccharides (HMO) Market, by Type, 2019 - 2032 (USD Million)
  • Table 54 Indonesia: Human Milk Oligosaccharides (HMO) Market, by Application, 2019 - 2032 (USD Million)
  • Table 55 Indonesia: Human Milk Oligosaccharides (HMO) Market, by Distribution channel, 2019 - 2032 (USD Million)
  • Table 56 South Korea: Human Milk Oligosaccharides (HMO) Market, by Type, 2019 - 2032 (USD Million)
  • Table 57 South Korea: Human Milk Oligosaccharides (HMO) Market, by Application, 2019 - 2032 (USD Million)
  • Table 58 South Korea: Human Milk Oligosaccharides (HMO) Market, by Distribution channel, 2019 - 2032 (USD Million)
  • Table 59 Middle East & Africa: Human Milk Oligosaccharides (HMO) Market, by Type, 2019 - 2032 (USD Million)
  • Table 60 Middle East & Africa: Human Milk Oligosaccharides (HMO) Market, by Application, 2019 - 2032 (USD Million)
  • Table 61 Middle East & Africa: Human Milk Oligosaccharides (HMO) Market, by Distribution channel, 2019 - 2032 (USD Million)
  • Table 62 Saudi Arabia: Human Milk Oligosaccharides (HMO) Market, by Type, 2019 - 2032 (USD Million)
  • Table 63 Saudi Arabia: Human Milk Oligosaccharides (HMO) Market, by Application, 2019 - 2032 (USD Million)
  • Table 64 Saudi Arabia: Human Milk Oligosaccharides (HMO) Market, by Distribution channel, 2019 - 2032 (USD Million)
  • Table 65 UAE: Human Milk Oligosaccharides (HMO) Market, by Type, 2019 - 2032 (USD Million)
  • Table 66 UAE: Human Milk Oligosaccharides (HMO) Market, by Application, 2019 - 2032 (USD Million)
  • Table 67 UAE: Human Milk Oligosaccharides (HMO) Market, by Distribution channel, 2019 - 2032 (USD Million)
  • Table 68 Israel: Human Milk Oligosaccharides (HMO) Market, by Type, 2019 - 2032 (USD Million)
  • Table 69 Israel: Human Milk Oligosaccharides (HMO) Market, by Application, 2019 - 2032 (USD Million)
  • Table 70 Israel: Human Milk Oligosaccharides (HMO) Market, by Distribution channel, 2019 - 2032 (USD Million)
  • Table 71 South Africa: Human Milk Oligosaccharides (HMO) Market, by Type, 2019 - 2032 (USD Million)
  • Table 72 South Africa: Human Milk Oligosaccharides (HMO) Market, by Application, 2019 - 2032 (USD Million)
  • Table 73 South Africa: Human Milk Oligosaccharides (HMO) Market, by Distribution channel, 2019 - 2032 (USD Million)
  • Table 74 Latin America: Human Milk Oligosaccharides (HMO) Market, by Type, 2019 - 2032 (USD Million)
  • Table 75 Latin America: Human Milk Oligosaccharides (HMO) Market, by Application, 2019 - 2032 (USD Million)
  • Table 76 Latin America: Human Milk Oligosaccharides (HMO) Market, by Distribution channel, 2019 - 2032 (USD Million)
  • Table 77 Mexico: Human Milk Oligosaccharides (HMO) Market, by Type, 2019 - 2032 (USD Million)
  • Table 78 Mexico: Human Milk Oligosaccharides (HMO) Market, by Application, 2019 - 2032 (USD Million)
  • Table 79 Mexico: Human Milk Oligosaccharides (HMO) Market, by Distribution channel, 2019 - 2032 (USD Million)
  • Table 80 Brazil: Human Milk Oligosaccharides (HMO) Market, by Type, 2019 - 2032 (USD Million)
  • Table 81 Brazil: Human Milk Oligosaccharides (HMO) Market, by Application, 2019 - 2032 (USD Million)
  • Table 82 Brazil: Human Milk Oligosaccharides (HMO) Market, by Distribution channel, 2019 - 2032 (USD Million)
  • Table 83 Argentina: Human Milk Oligosaccharides (HMO) Market, by Type, 2019 - 2032 (USD Million)
  • Table 84 Argentina: Human Milk Oligosaccharides (HMO) Market, by Application, 2019 - 2032 (USD Million)
  • Table 85 Argentina: Human Milk Oligosaccharides (HMO) Market, by Distribution channel, 2019 - 2032 (USD Million)

List of Figures

  • Figure 1. Global Human Milk Oligosaccharides (HMO) Market, 2019 - 2032 (USD Million)
  • Figure 2. Integrated Ecosystem
  • Figure 3. Research Methodology: Top-Down & Bottom-Up Approach
  • Figure 4. Market by Geography
  • Figure 5. Porter's Five Forces
  • Figure 6. Market by Application
  • Figure 7. Global Human Milk Oligosaccharides (HMO) Market, by Application, 2023 & 2032 (USD Million)
  • Figure 8. Market by Type
  • Figure 9. Global Human Milk Oligosaccharides (HMO) Market, by Type, 2023 & 2032 (USD Million)
  • Figure 10. Market by Distribution channel
  • Figure 11. Global Human Milk Oligosaccharides (HMO) Market, by Distribution channel, 2023 & 2032 (USD Million)
  • Figure 12. Human Milk Oligosaccharides (HMO) Market Assessment, By Geography, 2019 - 2032 (USD Million)
  • Figure 13. Strategic Analysis - Human Milk Oligosaccharides (HMO) Market